Literature DB >> 17568683

Direct costs associated with depression in old age in Germany.

Melanie Luppa1, Sven Heinrich, Herbert Matschinger, Hagen Sandholzer, Matthias C Angermeyer, Hans-Helmut König, Steffi G Riedel-Heller.   

Abstract

BACKGROUND: Depression in old age is common. Only few studies, exclusively conducted in the USA, have examined the impact of depression on direct costs in the elderly (60+). This study aims to determine the effect of depression on direct costs of the advanced elderly in Germany from a societal perspective.
METHODS: 451 primary care patients aged 75+ were investigated face-to-face regarding depressive symptoms (Geriatric Depression Scale), chronic medical illness (Chronic Disease Score) and resource utilisation and costs (cost diary). Resource utilisation was monetarily valued using 2004/2005 prices.
RESULTS: Mean annual direct costs of the depressed (euro5241) exceeded mean costs of non-depressed individuals (euro3648) by one third (p<.01). Significant differences were found for pharmaceutical costs, costs for medical supply and dentures, and for home care. Only few costs were caused by depression treatment. Depression has a significant impact on direct costs after controlling for age, gender, education, chronic medical illness and cognitive functions. A one-point increase in the GDS-Score was associated with a euro336 increase in the annual direct costs. LIMITATIONS: Reported costs can be considered as rather conservative estimates. There were no nursing home residents and no patients with dementia disorders in the sample. Furthermore, recall bias cannot be ruled out completely.
CONCLUSION: Depression in old age is associated with a significant increase of direct costs, even after adjustment for chronic medical illness. Future demographic changes in Germany will lead to an increase in the burden of old age depression. Therefore health policy should promote the development and use of cost-effective treatment strategies.

Entities:  

Mesh:

Year:  2007        PMID: 17568683     DOI: 10.1016/j.jad.2007.05.008

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  19 in total

1.  The economic burden of depression in Switzerland.

Authors:  Yuki Tomonaga; Josef Haettenschwiler; Martin Hatzinger; Edith Holsboer-Trachsler; Michael Rufer; Urs Hepp; Thomas D Szucs
Journal:  Pharmacoeconomics       Date:  2013-03       Impact factor: 4.981

2.  Ebola in the Netherlands, 2014-2015: costs of preparedness and response.

Authors:  Anita W M Suijkerbuijk; Corien M Swaan; Marie-Josee J Mangen; Johan J Polder; Aura Timen; Wilhelmina L M Ruijs
Journal:  Eur J Health Econ       Date:  2017-11-17

3.  The use of antidepressants in Belgian nursing homes: focus on indications and dosages in the PHEBE study.

Authors:  Jolyce Bourgeois; Monique M Elseviers; Luc Van Bortel; Mirko Petrovic; Robert H Vander Stichele
Journal:  Drugs Aging       Date:  2012-09       Impact factor: 3.923

4.  The effect of major and minor depression on Medicare home healthcare services use.

Authors:  Bruce Friedman; Rachel L Delavan; Thomas H Sheeran; Martha L Bruce
Journal:  J Am Geriatr Soc       Date:  2009-04       Impact factor: 5.562

Review 5.  [Depression in old age: challenge for aging societies].

Authors:  S G Riedel-Heller; S Weyerer; H-H König; M Luppa
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

Review 6.  [Collaborative and home based treatment for older adults with depression: a review of the literature].

Authors:  U Gühne; M Luppa; H-H König; S G Riedel-Heller
Journal:  Nervenarzt       Date:  2014-11       Impact factor: 1.214

7.  The Excess Costs of Depression and the Influence of Sociodemographic and Socioeconomic Factors: Results from the German Health Interview and Examination Survey for Adults (DEGS).

Authors:  Christian Brettschneider; Alexander Konnopka; Hannah König; Alexander Rommel; Julia Thom; Christian Schmidt; Hans-Helmut König
Journal:  Pharmacoeconomics       Date:  2021-02-01       Impact factor: 4.981

8.  Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings.

Authors:  Harald J Hamre; Claudia M Witt; Anja Glockmann; Renatus Ziegler; Gunver S Kienle; Stefan N Willich; Helmut Kiene
Journal:  Eur J Health Econ       Date:  2010-02

9.  Florbetaben PET in the Early Diagnosis of Alzheimer's Disease: A Discrete Event Simulation to Explore Its Potential Value and Key Data Gaps.

Authors:  Shien Guo; Denis Getsios; Luis Hernandez; Kelly Cho; Elizabeth Lawler; Arman Altincatal; Stephan Lanes; Michael Blankenburg
Journal:  Int J Alzheimers Dis       Date:  2012-12-26

10.  Psychiatric comorbidity as predictor of costs in back pain patients undergoing disc surgery: a longitudinal observational study.

Authors:  Alexander Konnopka; Margrit Löbner; Melanie Luppa; Dirk Heider; Sven Heinrich; Steffi Riedel-Heller; Hans Jörg Meisel; Lutz Günther; Jürgen Meixensberger; Hans-Helmut König
Journal:  BMC Musculoskelet Disord       Date:  2012-09-03       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.